Skip to main content
Journal cover image

Overtreatment and Deintensification of Diabetic Therapy among Medicare Beneficiaries.

Publication ,  Journal Article
Maciejewski, ML; Mi, X; Sussman, J; Greiner, M; Curtis, LH; Ng, J; Haffer, SC; Kerr, EA
Published in: J Gen Intern Med
January 2018

BACKGROUND: Deintensification of diabetic therapy is often clinically appropriate for older adults, because the benefit of aggressive diabetes treatment declines with age, while the risks increase. OBJECTIVE: We examined rates of overtreatment and deintensification of therapy for older adults with diabetes, and whether these rates differed by medical, demographic, and socioeconomic characteristics. DESIGN, SUBJECTS, AND MAIN MEASURES: We analyzed Medicare claims data from 10 states, linked to outpatient laboratory values to identify patients potentially overtreated for diabetes (HbA1c < 6.5% with fills for any diabetes medications beyond metformin, 1/1/2011-6/30/2011). We examined characteristics associated with deintensification for potentially overtreated diabetic patients. We used multinomial logistic regression to examine whether patient characteristics associated with overtreatment of diabetes differed from those associated with undertreatment (i.e. HbA1c > 9.0%). KEY RESULTS: Of 78,792 Medicare recipients with diabetes, 8560 (10.9%) were potentially overtreated. Overtreatment of diabetes was more common among those who were over 75 years of age and enrolled in Medicaid (p < 0.001), and was less common among Hispanics (p = 0.009). Therapy was deintensified for 14% of overtreated diabetics. Appropriate deintensification of diabetic therapy was more common for patients with six or more chronic conditions, more outpatient visits, or living in urban areas; deintensification was less common for those over age 75. Only 6.9% of Medicare recipients with diabetes were potentially undertreated. Variables associated with overtreatment of diabetes differed from those associated with undertreatment. CONCLUSIONS: Medicare recipients are more frequently overtreated than undertreated for diabetes. Medicare recipients who are overtreated for diabetes rarely have their regimens deintensified.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Gen Intern Med

DOI

EISSN

1525-1497

Publication Date

January 2018

Volume

33

Issue

1

Start / End Page

34 / 41

Location

United States

Related Subject Headings

  • United States
  • Medicare
  • Medical Overuse
  • Male
  • Hypoglycemic Agents
  • Humans
  • General & Internal Medicine
  • Female
  • Diabetes Mellitus
  • Cohort Studies
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Maciejewski, M. L., Mi, X., Sussman, J., Greiner, M., Curtis, L. H., Ng, J., … Kerr, E. A. (2018). Overtreatment and Deintensification of Diabetic Therapy among Medicare Beneficiaries. J Gen Intern Med, 33(1), 34–41. https://doi.org/10.1007/s11606-017-4167-y
Maciejewski, Matthew L., Xiaojuan Mi, Jeremy Sussman, Melissa Greiner, Lesley H. Curtis, Judy Ng, Samuel C. Haffer, and Eve A. Kerr. “Overtreatment and Deintensification of Diabetic Therapy among Medicare Beneficiaries.J Gen Intern Med 33, no. 1 (January 2018): 34–41. https://doi.org/10.1007/s11606-017-4167-y.
Maciejewski ML, Mi X, Sussman J, Greiner M, Curtis LH, Ng J, et al. Overtreatment and Deintensification of Diabetic Therapy among Medicare Beneficiaries. J Gen Intern Med. 2018 Jan;33(1):34–41.
Maciejewski, Matthew L., et al. “Overtreatment and Deintensification of Diabetic Therapy among Medicare Beneficiaries.J Gen Intern Med, vol. 33, no. 1, Jan. 2018, pp. 34–41. Pubmed, doi:10.1007/s11606-017-4167-y.
Maciejewski ML, Mi X, Sussman J, Greiner M, Curtis LH, Ng J, Haffer SC, Kerr EA. Overtreatment and Deintensification of Diabetic Therapy among Medicare Beneficiaries. J Gen Intern Med. 2018 Jan;33(1):34–41.
Journal cover image

Published In

J Gen Intern Med

DOI

EISSN

1525-1497

Publication Date

January 2018

Volume

33

Issue

1

Start / End Page

34 / 41

Location

United States

Related Subject Headings

  • United States
  • Medicare
  • Medical Overuse
  • Male
  • Hypoglycemic Agents
  • Humans
  • General & Internal Medicine
  • Female
  • Diabetes Mellitus
  • Cohort Studies